Skip to main content
SpringerLink
Log in

Fusion Inhibitors in HIV Infection

Summary and Table

  • Section 2: HIV Fusion Inhibitor
  • Adis Profile Summary
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kilby JM. Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors. Expert Opin Invest Drug 1999; 8 (8): 1157–70

    Article  CAS  Google Scholar 

  2. Proudfoot AEI, Wells TNC, Clapham PR. Chemokine receptors — future therapeutic targets for HIV? Biochem Pharmacol 1999; 57: 451–63

    Article  PubMed  CAS  Google Scholar 

  3. Cammack N. Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target. Antiviral Chem Chemother 1999; 10: 53–62

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adis International Limited, Auckland, New Zealand

    Michelle Wilde & Richelle Paterson

Authors
  1. Michelle Wilde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richelle Paterson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilde, M., Paterson, R. Fusion Inhibitors in HIV Infection. Drugs R&D 2, 333–335 (1999). https://doi.org/10.2165/00126839-199902050-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902050-00011

Keywords

Search

Navigation